Item Brochure

The Kimberly-Clark adVantage*
Knowledge networK* Accredited Education
Ongoing Customer Support
Expert Sales Force
Tools & Best Practices
Clinical Research
Commitment to Excellence
*Registered Trademark or Trademark of Kimberly-Clark Worldwide, Inc.
©2010 KCWW. All rights reserved. H01640 H0038-10-01
www.HAIwatch.com
Infection prevention website:
As a global leader in VAP prevention,
Kimberly-Clark offers a comprehensive
range of products, education, in-service
training, and compliance programs to assist
you as you develop your best-practice protocol
that can help protect your patients from VAP.
Kimberly-ClarK
*
KimVent
*
VAP Solutions:
Closed Suction Systems
Endotracheal Tubes
Bronchial Aspirate Sampling Catheter
Oral Care Solutions
VAP Solutions
KimVentKimVent
*
Kimberly-ClarK
*
Need Proof? Nearly 9 out of 10 clinicians would recommend KimVent* Oral Care!
User Results Show Preference For KimVent* 24-Hour Oral Care Kit:
For more information, please call your sales
representative, or visit our website at:
www.VAP.kchealthcare.com/oralcare
KimVent* Oral Care Kit (q4) Product Evaluation Survey
† Data was collected via self-administered product evaluation forms. A total of eleven (11) statements were
included on the form, using a 5-point agreement scale ranging from Strongly Disagree to Strongly Agree.
A total of 354 evaluation forms from 27 hospitals were completed by nurses and respiratory therapists and
returned to Kimberly-Clark Corp. Research was conducted with
KimVent* Oral Care q4 Kits only. Did not
include Chlorhexidine Gluconate Oral Rinse, 0.12%.
Users overwhelmingly agree that the Kimberly-ClarK*
KimVent* 24-Hour Oral Care Kit is:
• Easier to use
• Easier to follow and comply with protocol
• Encourages oral care frequency
Easier to use
• 87% of respondents think the kit is easier to use than their current product(s).
Easier to follow protocol
• The majority (89%) of respondents feel that the kit makes it easier
to follow oral care protocol.
Makes compliance easier
Most (86%) respondents agree that the kit makes it easier than their
previous methods to be compliant
Encourages oral care frequency
About 9 out of 10 (89%) respondents believe that the kit encourages
oral care frequency
More than 9 in 10 (92%) users feel that the packaging is easy to read
and serves as a visual reminder.
Makes oral care procedures less messy and less time consuming
The majority (88%) of respondents agree that the packaging makes
oral care procedures less messy and less time consuming.
Better tools for the job
Nine out of 10 users believe the self-cleaning Yankauer performs better
(90%) and requires less maintenance (91%) than previously used suction tools.
3
3
3
3
3
3
1. Kollef MH. What is ventilator-associated pneumonia and why is it important? Respiratory Care 2005 June; 50(6); 714-724
2. CDC. Guidelines for Preventing Healthcare-Associated Pneumonia, 2003. Recommendations of the CDC and the Healthcare Infection Control
Practices Advisory Committee. MMWR 2004; 53 (No. RR-3)
3. Fitch J. Oral Care in the ICU. American Journal of Critical Care 1999 Sept; Vol. 8 No. 5; 324-318.
4. Cason CL et al: Nurses’ implementation of guidelines for VAP from CDC, AM J Crit Care. 2007 Jan; 16(1).
5. Dennesen, P, et. al. Inadequate salivary flow and poor oral mucosal status in intubated intensive care unit patients, Crit Care Med 2003 Vol. 31, No. 3
6. Bagg, J. et al, Essentials for Microbiology, Chapter 21, Oxford University Press, 1999
7. Berry, A et al. Oral hygiene as a critical nursing activity in the intensive care unit. Intensive and Critical Care Nursing (2006) 22, 318-328.
8. Fourier. E. Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients
Intensive Care Med (2000) 26:1.
9. APIC. Preventing Ventilator-Associated Pneumonia 2004
10. AACN News Vol. 23 No. 8 Aug 2006
11. 5 Million Lives Campaign. Getting Started Kit: Prevent Ventilator-Associated Pneumonia How-to-Guide. Cambridge, MA: Crit Care Med
2003 Vol. 31, No.3
++ Rx Only
INDICATIONS FOR USE Chlorhexidine Gluconate Oral Rinse, 0.12% is indicated for use between dental visits as part of a professional program for the treatment of
gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. Chlorhexidine Gluconate Oral Rinse, 0.12% has not been
tested among patients with acute necrotizing ulcerative gingivitis (ANUG). For patients having coexisting gingivitis and periodontitis. See package insert for complete
prescribing information.
CONTRAINDICATIONS Chlorhexidine Gluconate Oral Rinse, 0.12% should not be used by persons who are known to be hypersensitive to chlorhexidine gluconate
or other formula ingredients.
ADVERSE REACTIONS The most common side effects associated with chlorhexidine gluconate oral rinses are 1) an increase in staining of teeth and other oral
surfaces; 2) an increase in calculus formation; and 3) an alteration in taste perception, see WARNINGS and PRECAUTIONS in package insert. Oral irritation and
local allergy-type symptoms have been spontaneously reported as side effects associated with use of chlorhexidine gluconate rinse. The following oral mucosal
side effects were reported during placebo-controlled adult clinical trials: aphthous ulcer, grossly obvious gingivitis, trauma, ulceration, erythema, desquamation,
coated tongue, keratinization, geographic tongue, mucocele, and short frenum. Each occurred at a frequency of less than 1.0%.Among post-marketing reports, the
most frequently reported oral mucosal symptoms associated with chlorhexidine gluconate oral rinse, 0.12% are stomatitis, gingivitis, glossitis, ulcer, dry mouth,
hypesthesia, glossal edema, and paresthesia. Minor irritation and superficial desquamation of the oral mucosa have been noted in patients using chlorhexidine
gluconate oral rinse, 0.12%.There have been cases of parotid gland swelling and inflammation of the salivary glands (sialadentis) reported in patients using
chlorhexidine gluconate oral rinse. WARNINGS The effect of Chlorhexidine Gluconate Oral Rinse, 0.12% on periodontitis has not been determined. An increase
in supragingival calculus was noted in clinical testing in users of chlorhexidine gluconate oral rinse compared with control users. It is not known if chlorhexidine
gluconate use results in an increase in subgingival calculus. Calculus deposits should be removed by a dental prophylaxis at intervals not greater than six months.
Hypersensitivity and generalized allergic reactions have occurred. You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit MedWatch or call 1-800-FDA-1088